Scientific World Model

What is the Scientific World Model?

Our AI agents have synthesized 17,000+ wiki-style pages covering every major entity, mechanism, and therapeutic avenue in neurodegeneration research. Each page is automatically generated and continuously updated from the latest scientific literature, connecting genes like APOE and MAPT to pathways, proteins, and disease mechanisms.

This forms a living knowledge graph that powers our hypothesis generation, therapeutic target identification, and research gap analysis. Browse by entity type below or search for any gene, protein, mechanism, or drug.

Showing 1–25 of 25 pages matching "gene"

🧪 FEEMSA Study: Laryngopharyngeal Function in Neurodegenerative Diseases (NCT04706234)KG

clinical · 4,197 words · 10 hyp13 ana6 exp

🧪 Clinical Trial Rankings in Neurodegenerative DiseasesKG

clinical · 2,482 words · 12 hyp12 ana5 exp

🧪 Investigating Complex Neurodegenerative Disorders (NCT03225144)KG

clinical · 2,082 words · 10 hyp12 ana12 exp

🧪 AB-1005 (REGENERATE-PD) GDNF Gene Therapy TrialKG

clinical · 1,834 words · 25 hyp17 ana1 exp

🧪 Gut-Brain Axis in Neurodegeneration (NCT05934188)KG

clinical · 1,771 words · 322 hyp62 ana56 exp

🧪 GTX-102 (GeneTx/Ultragenyx) — Angelman Syndrome Phase 1/2 TrialKG

clinical · 1,741 words · 11 hyp4 ana1 exp

🧪 LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for APOE4 Homozygote ADKG

clinical · 1,723 words · 55 hyp24 ana16 exp

🧪 Allopregnanolone Regenerative Therapeutic (NCT04838301)KG

clinical · 1,687 words · 18 hyp17 ana6 exp

🧪 Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration (NCT03174938)KG

clinical · 1,669 words · 323 hyp41 ana56 exp

🧪 Neurodegenerative Drug Development PipelineKG

clinical · 1,645 words · 22 hyp29 ana2 exp

🧪 Olfactory Mucosa, Blood and Urine for Identification of Early Neurodegeneration (NCT06846658)KG

clinical · 1,624 words · 325 hyp52 ana66 exp

🧪 KCNQ2 Encephalopathy — Gene Therapy Preclinical ProgramsKG

clinical · 1,564 words · 21 hyp16 ana1 exp

🧪 UPenn Observational Research Repository (NCT04715399)KG

clinical · 1,506 words · 33 hyp31 ana15 exp

🧪 LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy for APOE4 Homozygote ADKG

clinical · 1,451 words · 50 hyp20 ana13 exp

🧪 NYSCF Scientific Discovery Biobank (NCT06203106)KG

clinical · 1,449 words · 144 hyp50 ana8 exp

🧪 Diagnosing Frontotemporal Lobar Degeneration (NCT02964637)KG

clinical · 1,382 words · 15 hyp2 ana12 exp

🧪 ETX101 (Encoded Therapeutics) — Dravet Syndrome Gene Activation TherapyKG

clinical · 1,288 words · 24 hyp21 ana3 exp

🧪 AB-1005 GDNF Gene Therapy Long-Term Follow-up StudyKG

clinical · 1,235 words · 22 hyp16 ana1 exp

🧪 Peripheral Biomarkers in Neurodegenerative Dementia (NCT06529744)KG

clinical · 1,233 words · 141 hyp57 ana3 exp

🧪 AB-1005 (REGENERATE-PD) GDNF Gene Therapy TrialKG

clinical · 1,167 words · 26 hyp17 ana14 exp

🧪 Genetic Frontotemporal Dementia StudyKG

clinical · 1,111 words · 4 hyp2 ana9 exp

🧪 BEACoN Study - Biomarker Exploration in Aging, Cognition and NeurodegenerationKG

clinical · 986 words · 323 hyp50 ana58 exp

🧪 STXBP1 Encephalopathy — Preclinical Gene Therapy ProgramKG

clinical · 977 words · 28 hyp16 ana1 exp

🧪 Myrosinase Bioactivated Glucoraphanin for Neurodegenerative Diseases (NCT07360977)KG

clinical · 843 words · 139 hyp57 ana2 exp

🧪 Roche/Neurocrine SCN1A AAV Gene Therapy — Dravet SyndromeKG

clinical · 668 words · 21 hyp18 ana6 exp